spacer
spacer

PDBsum entry 1rdp

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Toxin PDB id
1rdp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
103 a.a.
Ligands
BV3 ×5
TRS
PGE
Waters ×494
PDB id:
1rdp
Name: Toxin
Title: Cholera toxin b-pentamer complexed with bivalent nitrophenol- galactoside ligand bv3
Structure: Cholera toxin b protein (ctb). Chain: d, e, f, g, h. Engineered: yes
Source: Vibrio cholerae. Organism_taxid: 666. Gene: ctxb. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Pentamer (from PQS)
Resolution:
1.35Å     R-factor:   0.132     R-free:   0.171
Authors: J.C.Pickens,D.D.Mitchell,J.Liu,X.Tan,Z.Zhang,C.L.Verlinde,W.G.Hol, E.Fan
Key ref:
J.C.Pickens et al. (2004). Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer. Chem Biol, 11, 1205-1215. PubMed id: 15380181 DOI: 10.1016/j.chembiol.2004.06.008
Date:
05-Nov-03     Release date:   26-Oct-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
P01556  (CHTB_VIBCH) -  Cholera enterotoxin subunit B from Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)
Seq:
Struc:
124 a.a.
103 a.a.*
Key:    Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 

 
DOI no: 10.1016/j.chembiol.2004.06.008 Chem Biol 11:1205-1215 (2004)
PubMed id: 15380181  
 
 
Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer.
J.C.Pickens, D.D.Mitchell, J.Liu, X.Tan, Z.Zhang, C.L.Verlinde, W.G.Hol, E.Fan.
 
  ABSTRACT  
 
A series of bivalent ligands of varying length were synthesized to inhibit the receptor-binding process of cholera toxin. Competitive surface receptor binding assays showed that significant potency gains relative to the constituent monovalent ligands were achieved independently from the ability of the extended bivalent ligands to span binding sites within the toxin pentamer. Several models that could account for the unexpected improvement in IC(50) values are examined, taking into account crystallographic analysis of each ligand in complex with the toxin pentamer. Evidence is presented that steric blocking at the receptor binding surface may play a role. The results of our study suggest that the use of relatively short, "nonspanning" bivalent ligands, or monovalent ligands of similar topology and bulk may be an effective way of blocking the interaction of multimeric proteins with their cell surface receptors.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Previously Studied Monovalent Ligands to CT and LT and Chemical Structure of Newly Synthesized Bivalent Ligands BV1–BV4
Figure 5.
Figure 5. Electron Density and Fitted Model(A) Electron density and model for BV1 in complex with CTB[5]. Electron density is contoured at 2σ in a σ[A]-weighted (mFo–DFc) difference map.(B) Electron density and model for BV4 in complex with CTB[5]. Electron density is contoured at 3σ in a σ[A]-weighted (mFo-DFc) difference map.
 
  The above figures are reprinted by permission from Cell Press: Chem Biol (2004, 11, 1205-1215) copyright 2004.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19034953 C.Sisu, A.J.Baron, H.M.Branderhorst, S.D.Connell, C.A.Weijers, R.de Vries, E.D.Hayes, A.V.Pukin, M.Gilbert, R.J.Pieters, H.Zuilhof, G.M.Visser, and W.B.Turnbull (2009).
The influence of ligand valency on aggregation mechanisms for inhibiting bacterial toxins.
  Chembiochem, 10, 329-337.  
18373548 J.Liu, D.Begley, D.D.Mitchell, C.L.Verlinde, G.Varani, and E.Fan (2008).
Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions.
  Chem Biol Drug Des, 71, 408-419.  
18692405 K.A.Schug, M.D.Joshi, P.Frycák, N.M.Maier, and W.Lindner (2008).
Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.
  J Am Soc Mass Spectrom, 19, 1629-1642.  
18666271 P.Rai, D.Vance, V.Poon, J.Mogridge, and R.S.Kane (2008).
Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids.
  Chemistry, 14, 7748-7751.  
19214239 S.Liu, and K.L.Kiick (2008).
Architecture Effects on the Binding of Cholera Toxin by Helical Glycopolypeptides.
  Macromolecules, 41, 764-772.  
19169374 B.D.Polizzotti, R.Maheshwari, J.Vinkenborg, and K.L.Kiick (2007).
Effects of Saccharide Spacing and Chain Extension on Toxin Inhibition by Glycopolypeptides of Well-Defined Architecture.
  Macromolecules, 40, 7103-7110.  
16471920 B.D.Polizzotti, and K.L.Kiick (2006).
Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers.
  Biomacromolecules, 7, 483-490.  
16305215 Y.Wang, and K.L.Kiick (2005).
Monodisperse protein-based glycopolymers via a combined biosynthetic and chemical approach.
  J Am Chem Soc, 127, 16392-16393.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer